Metformin Impedes Oxidation of LDL In Vitro

Metformin Impedes Oxidation of LDL In Vitro

Metformin is the most commonly prescribed glucose-lowering drug for the treatment of type 2 diabetes. The aim of this study was to investigate whether metformin is capable of impeding the oxidation of LDL, a crucial step in the development of endothelial dysfunction and atherosclerosis. LDL was oxid...

Full description

Bibliographic Details
Main Authors: Christine Rossmann, Cornelia Ranz, Gerd Kager, Gerhard Ledinski, Martin Koestenberger, Willibald Wonisch, Thomas Wagner, Sebastian P. Schwaminger, Bruno Di Geronimo, Andelko Hrzenjak, Seth Hallstöm, Gilbert Reibnegger, Gerhard Cvirn, Margret Paar
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Pharmaceutics
Subjects:
antioxidants
atherosclerosis
diabetes
copper ions
low density lipoprotein
lipid oxidation
Online Access:https://www.mdpi.com/1999-4923/15/8/2111

Internet

https://www.mdpi.com/1999-4923/15/8/2111

Similar Items